Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0900
+0.0100 (12.50%)
Aug 10, 2026, 1:44 PM EST
Lobe Sciences Balance Sheet
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Equivalents | 1.51 | 5.85 | 0.24 | 0.14 | 0.91 | 1.14 |
Short-Term Investments | 3.7 | 1.69 | 0.01 | 0.08 | 0.03 | 6.46 |
Cash & Short-Term Investments | 5.21 | 7.54 | 0.25 | 0.22 | 0.93 | 7.6 |
Cash Growth | -34.65% | 2925.68% | 12.95% | -76.35% | -87.72% | 3718.46% |
Other Receivables | 0.01 | 0.05 | 0.01 | 0.01 | 0.02 | 1.76 |
Receivables | 0.01 | 0.05 | 0.01 | 0.01 | 0.02 | 1.76 |
Inventory | - | - | - | 0.02 | - | - |
Prepaid Expenses | 0.07 | 0 | - | 0.07 | 0.08 | 0.11 |
Other Current Assets | 0.24 | - | - | - | - | 0.2 |
Total Current Assets | 5.53 | 7.59 | 0.26 | 0.32 | 1.04 | 9.67 |
Long-Term Investments | - | - | - | - | 0.68 | 2.32 |
Other Intangible Assets | - | - | - | 1.98 | 0.03 | 0.04 |
Total Assets | 5.53 | 7.59 | 0.26 | 2.3 | 1.75 | 12.1 |
Accounts Payable | 1.57 | 1.98 | 0.78 | 1.44 | 1.2 | 0.75 |
Accrued Expenses | - | - | - | 0.48 | 0.11 | 0.06 |
Short-Term Debt | - | - | - | 0.33 | - | - |
Current Portion of Long-Term Debt | 0.34 | - | 0.64 | - | - | - |
Current Income Taxes Payable | 0.24 | 0.24 | 0.24 | 0.21 | - | - |
Other Current Liabilities | 0.18 | 0.21 | 0.6 | - | - | - |
Total Current Liabilities | 2.33 | 2.43 | 2.27 | 2.46 | 1.3 | 0.8 |
Long-Term Debt | - | 0.27 | 1.11 | - | - | - |
Total Liabilities | 2.33 | 2.7 | 3.37 | 2.46 | 1.3 | 0.8 |
Common Stock | 35.91 | 34.71 | 30.61 | 27.62 | 25.22 | 24.84 |
Additional Paid-In Capital | - | - | - | - | 1.3 | 1.25 |
Retained Earnings | -42.87 | -39.25 | -40.1 | -35.68 | -30.98 | -18.47 |
Comprehensive Income & Other | 8.85 | 6.9 | 6.38 | 7.9 | 4.9 | 3.68 |
Total Common Equity | 1.89 | 2.36 | -3.11 | -0.16 | 0.45 | 11.29 |
Minority Interest | 1.32 | 2.53 | - | - | - | - |
Shareholders' Equity | 3.2 | 4.89 | -3.11 | -0.16 | 0.45 | 11.29 |
Total Liabilities & Equity | 5.53 | 7.59 | 0.26 | 2.3 | 1.75 | 12.1 |
Total Debt | 0.34 | 0.27 | 1.75 | 0.33 | - | - |
Net Cash (Debt) | 4.87 | 7.27 | -1.5 | -0.11 | 0.93 | 7.6 |
Net Cash Growth | -11.41% | - | - | - | -87.72% | - |
Net Cash Per Share | 0.02 | 0.05 | -0.01 | -0.00 | 0.02 | 0.23 |
Filing Date Shares Outstanding | 308.18 | 269.49 | 183.24 | 79.14 | 76.69 | 37.44 |
Total Common Shares Outstanding | 284.1 | 264.15 | 171.56 | 79.14 | 38.49 | 37.44 |
Working Capital | 3.2 | 5.16 | -2.01 | -2.14 | -0.27 | 8.86 |
Book Value Per Share | 0.01 | 0.01 | -0.02 | -0.00 | 0.01 | 0.30 |
Tangible Book Value | 1.89 | 2.36 | -3.11 | -2.14 | 0.42 | 11.25 |
Tangible Book Value Per Share | 0.01 | 0.01 | -0.02 | -0.03 | 0.01 | 0.30 |